Description

Retatrutide is a synthetic peptide-based compound designed to activate three metabolic hormone receptors: GLP-1, GIP, and glucagon receptors. In clinical and experimental research, it has been studied for its effects on appetite regulation, glucose metabolism, insulin signaling, energy expenditure, and body-weight control. Its triple-receptor activity makes it a useful model for examining how multiple incretin and metabolic pathways interact to influence broader endocrine and metabolic processes.